Cargando…

Corporate social responsibility of pharmaceutical industry in Korea

Background: Global pharmaceutical companies in Korea argue that the development of innovative drugs should be recognized as a social contribution, yet it has been countered by various stakeholders. The need to distinguish between philanthropic activities and Corporate Social Responsibility (CSR) of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Green, Ahn, Jeong-Hoon, Lim, Kyung-Min, Bae, SeungJin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445654/ https://www.ncbi.nlm.nih.gov/pubmed/36081939 http://dx.doi.org/10.3389/fphar.2022.950669

Ejemplares similares

How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea
por: Bae, SeungJin, et al.
Publicado: (2022)

Comparation of differences in the performance of corporate social responsibility between Chinese and American pharmaceutical enterprises—based on corporate social responsibility report
por: Xu, HongHao, et al.
Publicado: (2023)

Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea
por: Lee, Hankil, et al.
Publicado: (2019)

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
por: Kim, Yujeong, et al.
Publicado: (2020)

Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea
por: Lee, Munjae
Publicado: (2015)

Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate
por: Park, Jeewon, et al.
Publicado: (2020)

The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea
por: Shin, Gyeongseon, et al.
Publicado: (2022)

Transnational corporations in the pharmaceutical industry of developing countries.
Publicado: (1984)

Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
por: Son, Kyung-Bok, et al.
Publicado: (2019)

Consumers’ Corporate Social Responsibility Perception and Anti-Consumer Awareness: Roles of Compassion and Corporate Social Responsibility Authenticity in South Korea
por: Ko, Sung-Hoon, et al.
Publicado: (2023)

Pharmaceutical Industry’s Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers
por: Sung, Meekang, et al.
Publicado: (2021)

Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
por: Volodina, Anna, et al.
Publicado: (2009)

The Burden of Cervical Cancer in Korea: A Population-Based Study
por: Kim, Jinhee, et al.
Publicado: (2020)

Impact and challenges of enactment for advanced regenerative medicine in South Korea
por: Kim, Dong-Sook, et al.
Publicado: (2022)

Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea
por: Choi, Inseon, et al.
Publicado: (2020)

How Does Corporate Social Responsibility Affect Sustainability of Social Enterprises in Korea?
por: Qing, Chenglin, et al.
Publicado: (2022)

Future implications of ChatGPT in pharmaceutical industry: drug discovery and development
por: Zhao, Ailin, et al.
Publicado: (2023)

Evidence in Asian Food Industry: Intellectual Capital, Corporate Financial Performance, and Corporate Social Responsibility
por: Tsai, Cheng-Hung, et al.
Publicado: (2020)

Impact of High Fat Diet-induced Obesity on the Plasma Levels of Monoamine Neurotransmitters in C57BL/6 Mice
por: Kim, Minjeong, et al.
Publicado: (2013)

The illusion of righteousness: corporate social responsibility practices of the alcohol industry
por: Yoon, Sungwon, et al.
Publicado: (2013)

Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms
por: Droppert, Hayley, et al.
Publicado: (2015)

Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX
por: Scholz, Markus, et al.
Publicado: (2023)

The Impact of Compensation Gap on Corporate Innovation: Evidence from China’s Pharmaceutical Industry
por: Fu, Liping, et al.
Publicado: (2022)

Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement
por: Kim, Dong-Sook, et al.
Publicado: (2021)

Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market
por: Dănescu, Tatiana, et al.
Publicado: (2020)

Applications of Deep-Learning in Exploiting Large-Scale and Heterogeneous Compound Data in Industrial Pharmaceutical Research
por: David, Laurianne, et al.
Publicado: (2019)

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges
por: Mundy, Charles, et al.
Publicado: (2023)

Analysis of Statistical Methods Currently used in Toxicology Journals
por: Na, Jihye, et al.
Publicado: (2014)

Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea
por: Choi, Gyeyoung, et al.
Publicado: (2022)

Corporate Social Responsibility and Access to Policy Élites: An Analysis of Tobacco Industry Documents
por: Fooks, Gary J., et al.
Publicado: (2011)

Soda and Tobacco Industry Corporate Social Responsibility Campaigns: How Do They Compare?
por: Dorfman, Lori, et al.
Publicado: (2012)

Implementation Efficiency of Corporate Social Responsibility in the Construction Industry: A China Study
por: Wang, Xuetong, et al.
Publicado: (2018)

Datasets for corporate social responsibility index of Jordanian industrial and service sector firms
por: Alghizzawi, Moawiah Awad, et al.
Publicado: (2021)

Factors Affecting the Implementation of Corporate Social Responsibility in the Health Technology Industry in Greece
por: Liopa, Margarita, et al.
Publicado: (2023)

The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges
por: Khan, Shahzadgai, et al.
Publicado: (2020)

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry
por: Owusu-Asante, Mercy, et al.
Publicado: (2023)

Corporate social responsibility
por: Weber, James, et al.
Publicado: (2018)

Corporate social responsibility
por: Escobar-Pérez, Bernabé
Publicado: (2018)

Corporate social responsibility
por: Killian, Sheila
Publicado: (2012)

Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea
por: Kim, Do Yeun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rdvq7of8pgc0rid7ahdq0f83k5